BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 11927396)

  • 1. Atrial natriuretic factor and C-type natriuretic peptide induce retraction of human thyrocytes in monolayer culture via guanylyl cyclase receptors.
    Sellitti DF; Lagranha C; Perrella G; Curcio F; Doi SQ
    J Endocrinol; 2002 Apr; 173(1):169-76. PubMed ID: 11927396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. cAMP inhibits natriuretic peptide receptor-B activity and increases C-type natriuretic peptide in FRTL-5 rat thyroid cells.
    Sellitti DF; Puggina E; Lagranha C; Doi SQ
    J Endocrinol; 2004 Jan; 180(1):23-34. PubMed ID: 14709141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The receptor attributable to C-type natriuretic peptide-induced differentiation of osteoblasts is switched from type B- to type C-natriuretic peptide receptor with aging.
    Kaneki H; Kurokawa M; Ide H
    J Cell Biochem; 2008 Feb; 103(3):753-64. PubMed ID: 17562543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natriuretic peptides increase cAMP production in human thyrocytes via the natriuretic peptide clearance receptor (NPR-C).
    Sellitti DF; Perrella G; Doi SQ; Curcio F
    Regul Pept; 2001 Mar; 97(2-3):103-9. PubMed ID: 11164945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of natriuretic peptide receptors by thyrotropin in FRTL-5 rat thyroid cells: evidence for nonguanylate cyclase atrial natriuretic factor-binding sites in cells lacking the natriuretic peptide receptor C.
    Sellitti DF; Doi SQ
    Endocrinology; 1999 Mar; 140(3):1365-74. PubMed ID: 10067864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-type natriuretic Peptide down-regulates expression of its cognate receptor in rat aortic smooth muscle cells.
    Rahmutula D; Gardner DG
    Endocrinology; 2005 Nov; 146(11):4968-74. PubMed ID: 16109786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of natriuretic peptide receptors on ciliary body epithelial cells.
    Crook RB; Chang AT
    Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):49-55. PubMed ID: 9164840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic adenosine monophosphate (cAMP) increases natriuretic peptide receptor C (NPR-C) expression in human aortic smooth muscle cells.
    Puggina E; Sellitti D
    Mol Cell Endocrinol; 2004 Apr; 219(1-2):161-9. PubMed ID: 15149737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-type natriuretic peptide has a negative inotropic effect on cardiac myocytes.
    Nir A; Zhang DF; Fixler R; Burnett JC; Eilam Y; Hasin Y
    Eur J Pharmacol; 2001 Feb; 412(3):195-201. PubMed ID: 11166282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-type natriuretic peptide inhibits ANP secretion and atrial dynamics in perfused atria: NPR-B-cGMP signaling.
    Lee SJ; Kim SZ; Cui X; Kim SH; Lee KS; Chung YJ; Cho KW
    Am J Physiol Heart Circ Physiol; 2000 Jan; 278(1):H208-21. PubMed ID: 10644601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific potentiation by cyclic AMP of natriuretic peptide-mediated cyclic GMP production in adipose tissue.
    Thibault G; Lacasse A; Garcia R
    Life Sci; 1996; 58(25):2345-53. PubMed ID: 8649224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-type natriuretic peptide as a podocyte hormone and modulation of its cGMP production by glucose and mechanical stress.
    Lewko B; Endlich N; Kriz W; Stepinski J; Endlich K
    Kidney Int; 2004 Sep; 66(3):1001-8. PubMed ID: 15327393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysophosphatidic acid inhibits C-type natriuretic peptide activation of guanylyl cyclase-B.
    Abbey SE; Potter LR
    Endocrinology; 2003 Jan; 144(1):240-6. PubMed ID: 12488350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression and synthesis of natriuretic peptides determines natriuretic peptide receptor expression in primary cultures of human proximal tubular cells.
    Mistry SK; Hawksworth GM; Struthers AD; McLay JS
    J Hypertens; 2001 Feb; 19(2):255-62. PubMed ID: 11212968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling.
    Madhani M; Scotland RS; MacAllister RJ; Hobbs AJ
    Br J Pharmacol; 2003 Aug; 139(7):1289-96. PubMed ID: 12890708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling and distribution of NPR-Bi, the human splice form of the natriuretic peptide receptor type B.
    Hirsch JR; Skutta N; Schlatter E
    Am J Physiol Renal Physiol; 2003 Aug; 285(2):F370-4. PubMed ID: 12709393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingosine-1-phosphate inhibits C-type natriuretic peptide activation of guanylyl cyclase B (GC-B/NPR-B).
    Abbey-Hosch SE; Cody AN; Potter LR
    Hypertension; 2004 May; 43(5):1103-9. PubMed ID: 15037564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of natriuretic-peptide-induced growth inhibition of vascular smooth muscle cells.
    Hutchinson HG; Trindade PT; Cunanan DB; Wu CF; Pratt RE
    Cardiovasc Res; 1997 Jul; 35(1):158-67. PubMed ID: 9302360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The natriuretic peptides BNP and CNP increase heart rate and electrical conduction by stimulating ionic currents in the sinoatrial node and atrial myocardium following activation of guanylyl cyclase-linked natriuretic peptide receptors.
    Springer J; Azer J; Hua R; Robbins C; Adamczyk A; McBoyle S; Bissell MB; Rose RA
    J Mol Cell Cardiol; 2012 May; 52(5):1122-34. PubMed ID: 22326431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of C-type natriuretic peptide-induced endothelial cell hyperpolarization.
    Simon A; Harrington EO; Liu GX; Koren G; Choudhary G
    Am J Physiol Lung Cell Mol Physiol; 2009 Feb; 296(2):L248-56. PubMed ID: 19036874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.